Ayala Pharmaceuticals, Inc. reports

Company location: Monmouth Junction, NJ
Fiscal year end: 31 December

Ayala Pharmaceuticals, Inc. has filed 1,330 SEC EDGAR filings since 14 Dec 1999

Filter by type:
10-K
10-Q
8-K
SC13D
SC13G

SEC filing history

Showing 651-675 of 1,000 matching filings.

Per page

25

Current page

27

4

4 filing

Filing date: 02 Mar 2015
Reporting date: 27 Feb 2015
SEC evidence: Open document Open filing
Next action: Verify source filing

4

4 filing

Filing date: 02 Mar 2015
Reporting date: 27 Feb 2015
SEC evidence: Open document Open filing
Next action: Verify source filing

4

4 filing

Filing date: 25 Feb 2015
Reporting date: 24 Feb 2015
SEC evidence: Open document Open filing
Next action: Verify source filing

4

ADVAXIS, INC.

Filing date: 20 Feb 2015
Reporting date: 18 Feb 2015
SEC evidence: Open document Open filing
Next action: Verify source filing

8-K File 001-36138

8-K filing

Filing date: 19 Feb 2015
Reporting date: 19 Feb 2015
SEC evidence: Open document Open filing
Next action: Verify source filing

424B5 File 333-194009

424B5 filing

Filing date: 18 Feb 2015
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

S-3MEF File 333-202145

S-3MEF filing

Filing date: 18 Feb 2015
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

8-K File 001-36138

8-K filing

Filing date: 12 Feb 2015
Reporting date: 10 Feb 2015
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13G File 005-80101

ADXS AS OF 12/31/2014

Filing date: 10 Feb 2015
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

4

4 filing

Filing date: 04 Feb 2015
Reporting date: 03 Nov 2014
SEC evidence: Open document Open filing
Next action: Verify source filing

4

4 filing

Filing date: 04 Feb 2015
Reporting date: 03 Nov 2014
SEC evidence: Open document Open filing
Next action: Verify source filing

4

4 filing

Filing date: 04 Feb 2015
Reporting date: 03 Nov 2014
SEC evidence: Open document Open filing
Next action: Verify source filing

4

4 filing

Filing date: 04 Feb 2015
Reporting date: 03 Nov 2014
SEC evidence: Open document Open filing
Next action: Verify source filing

4

4 filing

Filing date: 04 Feb 2015
Reporting date: 03 Nov 2014
SEC evidence: Open document Open filing
Next action: Verify source filing

4

4 filing

Filing date: 04 Feb 2015
Reporting date: 03 Nov 2014
SEC evidence: Open document Open filing
Next action: Verify source filing

4

4 filing

Filing date: 04 Feb 2015
Reporting date: 10 Dec 2014
SEC evidence: Open document Open filing
Next action: Verify source filing

4

4 filing

Filing date: 04 Feb 2015
Reporting date: 30 Jan 2015
SEC evidence: Open document Open filing
Next action: Verify source filing

4

4 filing

Filing date: 04 Feb 2015
Reporting date: 10 Dec 2014
SEC evidence: Open document Open filing
Next action: Verify source filing

4

4 filing

Filing date: 04 Feb 2015
Reporting date: 10 Dec 2014
SEC evidence: Open document Open filing
Next action: Verify source filing

4

4 filing

Filing date: 04 Feb 2015
Reporting date: 10 Dec 2014
SEC evidence: Open document Open filing
Next action: Verify source filing

8-K File 001-36138

8-K filing

Filing date: 29 Jan 2015
Reporting date: 28 Jan 2015
SEC evidence: Open document Open filing
Next action: Verify source filing

EFFECT File 333-188637

EFFECT filing

Filing date: 26 Jan 2015
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

CORRESP

CORRESP filing

Filing date: 23 Jan 2015
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

8-K File 001-36138

CURRENT REPORT

Filing date: 23 Jan 2015
Reporting date: 22 Jan 2015
SEC evidence: Open document Open filing
Next action: Verify source filing

CORRESP

CORRESP filing

Filing date: 20 Jan 2015
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. to update or revoke optional consent for future visits. For more information, see our Privacy Policy .